Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori

Objective: The present study aims to compare the safety and efficacy of an amoxicillin/ilaprazole regimen with a bismuth quadruple regimen as the first-line treatment for eradicating Helicobacter pylori (H. pylori) infection.Methods: This was an open-label, randomized, single-center study involving...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Min Niu, Yan Zhou, Yunqian Xie, Xue Li, Yonggang Tian, Li Yao, Ximei Li, Hengjun Gao, Feihu Bai
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2022-04-01
Collection:Frontiers in Pharmacology
Sujets:
Helicobacter pylori
bismuth quadruple therapy
double therapy
clinical trial
eradication rate
Accès en ligne:https://www.frontiersin.org/articles/10.3389/fphar.2022.771876/full
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires